<DOC>
	<DOCNO>NCT00315380</DOCNO>
	<brief_summary>Eosinophilic granulomatosis polyangiitis ( Churg-Strauss ) ( EGPA ) rare immune system disorder cause asthma , excessive number eosinophil ( type white blood cell ) blood , inflammation blood vessel , vasculitis . In order properly treat EGPA , critical level disease activity determine course disease . The purpose study determine new biological marker , biomarkers , may use assess severity disease people EGPA .</brief_summary>
	<brief_title>Determining Disease Activity Biomarkers Individuals With Eosinophilic Granulomatosis With Polyangiitis ( Churg-Strauss )</brief_title>
	<detailed_description>EGPA , also know allergic granulomatosis angiitis , systemic vasculitis . EGPA mark three distinct symptom : asthma ; eosinophilia , evidence excessive number eosinophil blood tissue ; vasculitis involve skin , lung , nerve , kidney , organ . Nerve involvement may also occur EGPA , cause pain , tingling , numbness , muscle waste hand foot . Because EGPA patient may show visible sign active disease , current method monitor disease progression usually represent period extend inflammation disease activity . Thus , patient may go untreated period undetectable disease damage might preventable . This study use novel scientific method identify new biomarkers use monitor disease activity EGPA patient . These biomarkers may use help direct clinical care EGPA patient assist future drug development . Study visit occur monthly first year , every 3 month thereafter remainder study . Blood urine collection occur every visit . A physical exam medical medication history occur every 3 month ; also , participant ask complete several questionnaire assess disease activity , health status , tobacco , alcohol , drug use . Participants may additional study visit disease flare disease-related complication occur study .</detailed_description>
	<mesh_term>Systemic Vasculitis</mesh_term>
	<mesh_term>Granulomatosis Polyangiitis</mesh_term>
	<mesh_term>Churg-Strauss Syndrome</mesh_term>
	<criteria>Documented evidence small vessel vasculitis least 4 follow 6 American College Rheumatology ( ACR ) criteria diagnosis eosinophilic granulomatosis polyangiitis ( ChurgStrauss ) : 1 . Asthma 2 . Peak peripheral blood eosinophilia great 10 % total white blood cell count 3 . Peripheral neuropathy attributable vasculitis 4 . Transient pulmonary infiltrates chest image study 5 . Paranasal sinus abnormality nasal polyposis 6 . Eosinophilic inflammation tissue biopsy Parent guardian willing provide inform consent , applicable Granulomatosis polyangiitis ( Wegener 's ) Microscopic polyangiitis Druginduced vasculitis Hypereosinophilic syndrome Sarcoidosis Infectious form vasculitis Takayasu 's arteritis Giant cell arteritis Cogan 's syndrome Behcet 's disease Kawasaki disease Cryoglobulinemic vasculitis Systemic lupus erythematosus Rheumatoid arthritis Mixed connective tissue disease overlap autoimmune syndrome</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>EGPA</keyword>
	<keyword>CSS</keyword>
</DOC>